logo

For the Inventor, By the Inventor

Madison, WI, United States of America

Epicentre Technologies Corporation


USPTO Granted Patents = 28

% Expired Patents = 21.4



Trademarks = 3

Forward Citations = 869

Loading Chart...
Loading Chart...

15 inventors (with patents filed for the assignee):

goldMedal Jerome J Jendrisak (20 out of 43 patents)

silverMedal Gary A Dahl (15 out of 38 patents)

bronzeMedal Ramesh Vaidyanathan (6 out of 17 patents)

4.  Haiying Li Grunenwald (6 out of 14 patents)

5.  Nicholas Caruccio (5 out of 10 patents)

6.  Leslie M Hoffman (5 out of 10 patents)

7.  Scott Kuersten (3 out of 12 patents)

8.  Agnes Radek (3 out of 5 patents)

9.  Rui Sousa (3 out of 7 patents)

10.  Robert E Smith (3 out of 3 patents)

11.  Ken Doyle (2 out of 2 patents)

12.  Darin J Haskins (2 out of 6 patents)

13.  Michael J Fiandt (2 out of 3 patents)

14.  Roy Rabindranauth Sooknanan (1 out of 16 patents)

15.  Gregory A Hawkins (1 out of 2 patents)


Core Competencies:
Nucleic Acids
RNA
Transposon
Riboprimers
DNA Amplification
Plasmids
Thermostable Ribonuclease
Replicase Substrate
Copy Number
Assays
Polypeptides
Mutation

28 patents:

1. 10640809 - Methods of analyzing nucleic acids (2020-05-05),
2. 10184122 - Transposon end compositions and methods for modifying nucleic acids (2019-01-22),
3. 9963735 - Selective 5' ligation tagging of RNA (2018-05-08),
4. 9790540 - Methods and kits for 3'-end-tagging of RNA (2017-10-17),
5. 9745570 - Methods, compositions, and kits for generating rRNA-depleted samples or isolating rRNA from samples (2017-08-29),
6. 9115396 - Transposon end compositions and methods for modifying nucleic acids (2015-08-25),
7. 9085801 - Transposon end compositions and methods for modifying nucleic acids (2015-07-21),
8. 9080211 - Transposon end compositions and methods for modifying nucleic acids (2015-07-14),
9. 9040256 - Transposon end compositions and methods for modifying nucleic acids (2015-05-26),
10. 8574864 - Methods and kits for 3'-end-tagging of RNA (2013-11-05),
11. 8309335 - Selective 5' ligation tagging of RNA (2012-11-13),
12. 8163491 - Selective 5' ligation tagging of RNA (2012-04-24),
13. 7794971 - Compositions and methods for controlling copy number for a broad range of plasmids and uses thereof (2010-09-14),
14. 7727744 - Methods for obtaining directionally truncated polypeptides (2010-06-01),
15. 7659072 - Methods for using riboprimers for strand displacement replication of target sequences (2010-02-09),
Company Overview
Epicentre Technologies Corporation, based in Madison, WI, specializes in the development of innovative solutions in the field of biotechnology. The company focuses on advancing research tools and technologies that enhance the capabilities of scientists and researchers in various domains, including genomics and molecular biology. By leveraging cutting-edge methodologies, Epicentre aims to facilitate breakthroughs in life sciences, contributing to the broader scientific community and fostering advancements in health and medicine.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

28 Patents

#33 in Madison, WI

#287 in Wisconsin

#12,016 in US

#23,299 in the World

Madison, WI (US)
Madison, WI, United States of America

Epicentre Technologies Corporation

Forward Citations = 869

15 inventors:

goldMedal Jerome J Jendrisak (20 out of 43 patents)

silverMedal Gary A Dahl (15 out of 38 patents)

bronzeMedal Ramesh Vaidyanathan (6 out of 17 patents)

4.  Haiying Li Grunenwald (6 out of 14 patents)

5.  Nicholas Caruccio (5 out of 10 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Epicentre Technologies Corporation. Retrieved from https://idiyas.com/company/epicentre-technologies

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…